Time & Date: 2 September, 16:15 – 17:15 CEST
Moderator: J. Garweg SWITZERLAND
Speakers & Presentations:
J. Garweg SWITZERLAND
16:15 Welcome
E. Aydin TURKEY
16:17 The Investigation of Relationship between Diabetes, Diabetic Neuropathy, and Retinal Neurodegeneration
T-E. Tan SINGAPORE
16:22 Retinal Neural Dysfunction in Diabetes Revealed with Handheld Chromatic Pupillometry
P. Schlottmann ARGENTINA
16:27 Efficacy, Durability and Safety of Faricimab in Diabetic Macular Edema: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
M. Barakat USA
16:32 Brolucizumab for the Treatment of Diabetic Macular Edema: 52-week Results from the KINGFISHER Study
J. Garweg SWITZERLAND
16:37 Brolucizumab for treatment of diabetic macular edema (DME): 100-week results from the KESTREL and KITE studies
R. Khoramnia GERMANY
16:42 Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): 3-year results from the European IRISS registry study
J. Garweg SWITZERLAND
16:47 Effect of Finerenone on Occurrence of Vision-threatening Events in Patients with DR
A.M. Martínez SPAIN
16:52 Anatomical biomarkers after dexamethasone intravitreal implant in diabetic macular edema patients according to new ESASO Classification
All Faculty
16:57 Discussion
